Captario Named Top 50 Innovators of the Year by CIO Bulletin

Having experienced one of the biggest health crises the modern world has witnessed, it has become alarmingly apparent that continuous innovation in pharmaceutical drug development is essential. New drugs are essential for many reasons, such as new diseases, our increasing understanding of health conditions allowing treatment of previously untreatable conditions, and the development of drug resistance.

Whatever the reason, drug development’s ultimate goal is to bring a new compound with a proven therapeutic effect to the market. But the drug development process is tedious and fraught with many dangers and potential risks. Captario enables drug development and commercialization organizations to make better strategic decisions through its innovative cloud-based simulation software, Captario SUM® (Strategic Uncertainty Management).


Read the Full Article Here.